Rockwell Medical Inc
NASDAQ:RMTI

Watchlist Manager
Rockwell Medical Inc Logo
Rockwell Medical Inc
NASDAQ:RMTI
Watchlist
Price: 2.13 USD -4.48%
Market Cap: 68.8m USD
Have any thoughts about
Rockwell Medical Inc?
Write Note

Rockwell Medical Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rockwell Medical Inc
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Rockwell Medical Inc
NASDAQ:RMTI
Other Liabilities
$4.3m
CAGR 3-Years
-28%
CAGR 5-Years
-19%
CAGR 10-Years
-10%
Haemonetics Corp
NYSE:HAE
Other Liabilities
$90m
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
10%
ICU Medical Inc
NASDAQ:ICUI
Other Liabilities
$112.8m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
45%
Align Technology Inc
NASDAQ:ALGN
Other Liabilities
$358m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
29%
Lantheus Holdings Inc
NASDAQ:LNTH
Other Liabilities
$85.2m
CAGR 3-Years
-7%
CAGR 5-Years
9%
CAGR 10-Years
8%
Merit Medical Systems Inc
NASDAQ:MMSI
Other Liabilities
$97.5m
CAGR 3-Years
-4%
CAGR 5-Years
-10%
CAGR 10-Years
20%
No Stocks Found

Rockwell Medical Inc
Glance View

Market Cap
68.8m USD
Industry
Health Care

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.

RMTI Intrinsic Value
1.23 USD
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Rockwell Medical Inc's Other Liabilities?
Other Liabilities
4.3m USD

Based on the financial report for Sep 30, 2024, Rockwell Medical Inc's Other Liabilities amounts to 4.3m USD.

What is Rockwell Medical Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
-10%

Over the last year, the Other Liabilities growth was -8%. The average annual Other Liabilities growth rates for Rockwell Medical Inc have been -28% over the past three years , -19% over the past five years , and -10% over the past ten years .

Back to Top